2167274|t|Spin-labelling studies of the interaction of 9-amino-1,2,3,4-tetrahydroacridine (THA), a proposed drug for the treatment of Alzheimer's disease, with erythrocyte membranes.
2167274|a|ESR spin labels specific for skeletal proteins or cell-surface sialic acid have been used to monitor the interaction of 9-amino-1,2,3,4-tetrahydroacridine (THA) and its structural analogs with human erythrocyte membranes. The results suggest that THA significantly increases skeletal protein-protein interactions and may secondarily alter the physical state of the opposite side of the membrane. The fully aromatic analog of THA, 9-aminoacridine, showed even more pronounced effects on skeletal proteins than did THA. These results are discussed in relation to possible interaction sites of THA in erythrocyte ghosts and to potential mechanisms by which THA reportedly increases mental function of victims of Alzheimer's disease.
2167274	0	4	Spin	Chemical	-
2167274	45	79	9-amino-1,2,3,4-tetrahydroacridine	Chemical	MESH:D013619
2167274	81	84	THA	Chemical	MESH:D013619
2167274	124	143	Alzheimer's disease	Disease	MESH:D000544
2167274	177	181	spin	Chemical	-
2167274	236	247	sialic acid	Chemical	MESH:D019158
2167274	293	327	9-amino-1,2,3,4-tetrahydroacridine	Chemical	MESH:D013619
2167274	329	332	THA	Chemical	MESH:D013619
2167274	366	371	human	Species	9606
2167274	420	423	THA	Chemical	MESH:D013619
2167274	598	601	THA	Chemical	MESH:D013619
2167274	603	618	9-aminoacridine	Chemical	MESH:D000585
2167274	686	689	THA	Chemical	MESH:D013619
2167274	764	767	THA	Chemical	MESH:D013619
2167274	827	830	THA	Chemical	MESH:D013619
2167274	882	901	Alzheimer's disease	Disease	MESH:D000544
2167274	Negative_Correlation	MESH:D013619	MESH:D000544

